ArticlePloS one2024
Use machine learning models to identify and assess risk factors for coronary artery disease.
Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Machine Learning-Based Prediction of Coronary Artery Disease Using Clinical and Behavioral Data: A Comparative Study.Diagnostics (Basel, Switzerland) · 2026Article
- Interpretable machine learning for predicting major amputation risk in hospitalized diabetic foot ulcer patients: a single-center study with temporal external validation.Frontiers in endocrinology · 2026Article
- Article
- An effective multi-step feature selection framework for clinical outcome prediction using electronic medical records.BMC medical informatics and decision making · 2025Article
- Machine Learning-Driven Prediction of One-Year Readmission in HFrEF Patients: The Key Role of Inflammation.Clinical interventions in aging · 2025Article
- Identifying risk factors and predicting stroke using Bayesian networks: Evidence from NHANES 2011-2020.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Accurate prediction of coronary artery disease (CAD) is crucial for enabling early clinical diagnosis and tailoring personalized treatment options. This study attempts to construct a machine learning (ML) model for predicting CAD risk and further elucidate the complex nonlinear interactions between the disease and its risk factors. Employing the Z-Alizadeh Sani dataset, which includes records of 303 patients, univariate analysis and the Boruta algorithm were applied for feature selection, and nine different ML techniques were subsequently deployed to produce predictive models. To elucidate the intricate pathogenesis of CAD, this study harnessed the analytical capabilities of Shapley values, alongside the use of generalized additive models for curve fitting, to probe into the nonlinear interactions between the disease and its associated risk factors. Furthermore, we implemented a piecewise linear regression model to precisely pinpoint inflection points within these complex nonlinear dynamics. The findings of this investigation reveal that logistic regression (LR) stands out as the preeminent predictive model, demonstrating remarkable efficacy, it achieved an Area Under the Receiver Operating Characteristic curve (AUROC) of 0.981 (95% CI: 0.952-1), and an Area Under the Precision-Recall Curve (AUPRC) of 0.993. The utilization of the 14 most pivotal features in constructing a dynamic nomogram. Analysis of the Shapley smoothing curves uncovered distinctive "S"-shaped and "C"-shaped relationships linking age and triglycerides to CAD, respectively. In summary, machine learning models could provide valuable insights for the early diagnosis of CAD. The SHAP method may provide a personalized risk assessment of the relationship between CAD and its risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.